Selected research
Industry Research
Candida Infection Testing Industry Research Report 2026
Market perspective
The global Candida Infection Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Candida Infection Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Candida Infection Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Candida Infection Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Candida Infection Testing include Roche Diagnostics, Abbott Diagnostics, bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Siemens Healthineers, Bruker, Danaher and QuidelOrtho, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Candida Infection Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Candida Infection Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Candida Infection Testing Market by Company
Roche Diagnostics
Abbott Diagnostics
bioMérieux
Becton Dickinson
Thermo Fisher Scientific
Siemens Healthineers
Bruker
Danaher
QuidelOrtho
Luminex
Hologic
Sysmex
Bio‑Rad Laboratories
Cepheid
Qiagen
ARUP Laboratories
Labcorp
Quest Diagnostics
Eurofins Scientific
Synlab
Candida Infection Testing Segment by Type
Traditional Culture
Molecular Biology Detection
Candida Infection Testing Segment by Application
Medical
Maternal and Child Health
Physical Examination
Aesthetic Medicine
Other
Candida Infection Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candida Infection Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Candida Infection Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candida Infection Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Candida Infection Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Traditional Culture
- Molecular Biology Detection
Applications
- Medical
- Maternal and Child Health
- Physical Examination
- Aesthetic Medicine
- Other
Companies covered
- Roche Diagnostics
- Abbott Diagnostics
- bioMérieux
- Becton Dickinson
- Thermo Fisher Scientific
- Siemens Healthineers
- Bruker
- Danaher
- QuidelOrtho
- Luminex
- Hologic
- Sysmex
- Bio‑Rad Laboratories
- Cepheid
- Qiagen
- ARUP Laboratories
- Labcorp
- Quest Diagnostics
- Eurofins Scientific
- Synlab
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Candida Infection Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Traditional Culture
- 2.2.3 Molecular Biology Detection
- 2.3 Candida Infection Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical
- 2.3.3 Maternal and Child Health
- 2.3.4 Physical Examination
- 2.3.5 Aesthetic Medicine
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Candida Infection Testing Breakdown Data by Type
- 3.1 Global Candida Infection Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Candida Infection Testing Forecasted Market Size by Type (2027-2032)
4 Candida Infection Testing Breakdown Data by Application
- 4.1 Global Candida Infection Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Candida Infection Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Candida Infection Testing Market Perspective (2021-2032)
- 5.2 Global Candida Infection Testing Growth Trends by Region
- 5.2.1 Global Candida Infection Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Candida Infection Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Candida Infection Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Candida Infection Testing Market Dynamics
- 5.3.1 Candida Infection Testing Industry Trends
- 5.3.2 Candida Infection Testing Market Drivers
- 5.3.3 Candida Infection Testing Market Challenges
- 5.3.4 Candida Infection Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Candida Infection Testing Players by Revenue
- 6.1.1 Global Top Candida Infection Testing Players by Revenue (2021-2026)
- 6.1.2 Global Candida Infection Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Candida Infection Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Candida Infection Testing Head Office and Area Served
- 6.4 Global Candida Infection Testing Players, Product Type & Application
- 6.5 Global Candida Infection Testing Manufacturers Established Date
- 6.6 Global Candida Infection Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Candida Infection Testing Market Size (2021-2032)
- 7.2 North America Candida Infection Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Candida Infection Testing Market Size by Country (2021-2026)
- 7.4 North America Candida Infection Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Candida Infection Testing Market Size (2021-2032)
- 8.2 Europe Candida Infection Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Candida Infection Testing Market Size by Country (2021-2026)
- 8.4 Europe Candida Infection Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Candida Infection Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Candida Infection Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Candida Infection Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Candida Infection Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Candida Infection Testing Market Size (2021-2032)
- 10.2 South America Candida Infection Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Candida Infection Testing Market Size by Country (2021-2026)
- 10.4 South America Candida Infection Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Candida Infection Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Candida Infection Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Candida Infection Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Candida Infection Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche Diagnostics
- 12.1.1 Roche Diagnostics Company Information
- 12.1.2 Roche Diagnostics Business Overview
- 12.1.3 Roche Diagnostics Revenue in Candida Infection Testing Business (2021-2026)
- 12.1.4 Roche Diagnostics Candida Infection Testing Product Portfolio
- 12.1.5 Roche Diagnostics Recent Developments
- 12.2 Abbott Diagnostics
- 12.2.1 Abbott Diagnostics Company Information
- 12.2.2 Abbott Diagnostics Business Overview
- 12.2.3 Abbott Diagnostics Revenue in Candida Infection Testing Business (2021-2026)
- 12.2.4 Abbott Diagnostics Candida Infection Testing Product Portfolio
- 12.2.5 Abbott Diagnostics Recent Developments
- 12.3 bioMérieux
- 12.3.1 bioMérieux Company Information
- 12.3.2 bioMérieux Business Overview
- 12.3.3 bioMérieux Revenue in Candida Infection Testing Business (2021-2026)
- 12.3.4 bioMérieux Candida Infection Testing Product Portfolio
- 12.3.5 bioMérieux Recent Developments
- 12.4 Becton Dickinson
- 12.4.1 Becton Dickinson Company Information
- 12.4.2 Becton Dickinson Business Overview
- 12.4.3 Becton Dickinson Revenue in Candida Infection Testing Business (2021-2026)
- 12.4.4 Becton Dickinson Candida Infection Testing Product Portfolio
- 12.4.5 Becton Dickinson Recent Developments
- 12.5 Thermo Fisher Scientific
- 12.5.1 Thermo Fisher Scientific Company Information
- 12.5.2 Thermo Fisher Scientific Business Overview
- 12.5.3 Thermo Fisher Scientific Revenue in Candida Infection Testing Business (2021-2026)
- 12.5.4 Thermo Fisher Scientific Candida Infection Testing Product Portfolio
- 12.5.5 Thermo Fisher Scientific Recent Developments
- 12.6 Siemens Healthineers
- 12.6.1 Siemens Healthineers Company Information
- 12.6.2 Siemens Healthineers Business Overview
- 12.6.3 Siemens Healthineers Revenue in Candida Infection Testing Business (2021-2026)
- 12.6.4 Siemens Healthineers Candida Infection Testing Product Portfolio
- 12.6.5 Siemens Healthineers Recent Developments
- 12.7 Bruker
- 12.7.1 Bruker Company Information
- 12.7.2 Bruker Business Overview
- 12.7.3 Bruker Revenue in Candida Infection Testing Business (2021-2026)
- 12.7.4 Bruker Candida Infection Testing Product Portfolio
- 12.7.5 Bruker Recent Developments
- 12.8 Danaher
- 12.8.1 Danaher Company Information
- 12.8.2 Danaher Business Overview
- 12.8.3 Danaher Revenue in Candida Infection Testing Business (2021-2026)
- 12.8.4 Danaher Candida Infection Testing Product Portfolio
- 12.8.5 Danaher Recent Developments
- 12.9 QuidelOrtho
- 12.9.1 QuidelOrtho Company Information
- 12.9.2 QuidelOrtho Business Overview
- 12.9.3 QuidelOrtho Revenue in Candida Infection Testing Business (2021-2026)
- 12.9.4 QuidelOrtho Candida Infection Testing Product Portfolio
- 12.9.5 QuidelOrtho Recent Developments
- 12.10 Luminex
- 12.10.1 Luminex Company Information
- 12.10.2 Luminex Business Overview
- 12.10.3 Luminex Revenue in Candida Infection Testing Business (2021-2026)
- 12.10.4 Luminex Candida Infection Testing Product Portfolio
- 12.10.5 Luminex Recent Developments
- 12.11 Hologic
- 12.11.1 Hologic Company Information
- 12.11.2 Hologic Business Overview
- 12.11.3 Hologic Revenue in Candida Infection Testing Business (2021-2026)
- 12.11.4 Hologic Candida Infection Testing Product Portfolio
- 12.11.5 Hologic Recent Developments
- 12.12 Sysmex
- 12.12.1 Sysmex Company Information
- 12.12.2 Sysmex Business Overview
- 12.12.3 Sysmex Revenue in Candida Infection Testing Business (2021-2026)
- 12.12.4 Sysmex Candida Infection Testing Product Portfolio
- 12.12.5 Sysmex Recent Developments
- 12.13 Bio‑Rad Laboratories
- 12.13.1 Bio‑Rad Laboratories Company Information
- 12.13.2 Bio‑Rad Laboratories Business Overview
- 12.13.3 Bio‑Rad Laboratories Revenue in Candida Infection Testing Business (2021-2026)
- 12.13.4 Bio‑Rad Laboratories Candida Infection Testing Product Portfolio
- 12.13.5 Bio‑Rad Laboratories Recent Developments
- 12.14 Cepheid
- 12.14.1 Cepheid Company Information
- 12.14.2 Cepheid Business Overview
- 12.14.3 Cepheid Revenue in Candida Infection Testing Business (2021-2026)
- 12.14.4 Cepheid Candida Infection Testing Product Portfolio
- 12.14.5 Cepheid Recent Developments
- 12.15 Qiagen
- 12.15.1 Qiagen Company Information
- 12.15.2 Qiagen Business Overview
- 12.15.3 Qiagen Revenue in Candida Infection Testing Business (2021-2026)
- 12.15.4 Qiagen Candida Infection Testing Product Portfolio
- 12.15.5 Qiagen Recent Developments
- 12.16 ARUP Laboratories
- 12.16.1 ARUP Laboratories Company Information
- 12.16.2 ARUP Laboratories Business Overview
- 12.16.3 ARUP Laboratories Revenue in Candida Infection Testing Business (2021-2026)
- 12.16.4 ARUP Laboratories Candida Infection Testing Product Portfolio
- 12.16.5 ARUP Laboratories Recent Developments
- 12.17 Labcorp
- 12.17.1 Labcorp Company Information
- 12.17.2 Labcorp Business Overview
- 12.17.3 Labcorp Revenue in Candida Infection Testing Business (2021-2026)
- 12.17.4 Labcorp Candida Infection Testing Product Portfolio
- 12.17.5 Labcorp Recent Developments
- 12.18 Quest Diagnostics
- 12.18.1 Quest Diagnostics Company Information
- 12.18.2 Quest Diagnostics Business Overview
- 12.18.3 Quest Diagnostics Revenue in Candida Infection Testing Business (2021-2026)
- 12.18.4 Quest Diagnostics Candida Infection Testing Product Portfolio
- 12.18.5 Quest Diagnostics Recent Developments
- 12.19 Eurofins Scientific
- 12.19.1 Eurofins Scientific Company Information
- 12.19.2 Eurofins Scientific Business Overview
- 12.19.3 Eurofins Scientific Revenue in Candida Infection Testing Business (2021-2026)
- 12.19.4 Eurofins Scientific Candida Infection Testing Product Portfolio
- 12.19.5 Eurofins Scientific Recent Developments
- 12.20 Synlab
- 12.20.1 Synlab Company Information
- 12.20.2 Synlab Business Overview
- 12.20.3 Synlab Revenue in Candida Infection Testing Business (2021-2026)
- 12.20.4 Synlab Candida Infection Testing Product Portfolio
- 12.20.5 Synlab Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst